FDA Approves New Long-Acting HIV Prevention Drug Offering Hope and Affordability
TL;DR Summary
The FDA has approved lenacapavir, a groundbreaking injectable drug that offers near-complete protection against HIV with just two doses a year, representing a significant advancement in HIV prevention, though high costs and access issues remain challenges.
- HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda NPR
- Regulators Approve Lenacapavir for H.I.V. Prevention The New York Times
- FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option CNBC
- FDA approves powerful HIV prevention drug: What to know about Yeztugo NBC News
- ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers The Guardian
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
5 min
vs 5 min read
Condensed
96%
988 → 36 words
Want the full story? Read the original article
Read on NPR